Adagio Medical Holdings (ADGM) Liabilities and Shareholders Equity (2023 - 2026)
Adagio Medical Holdings has reported Liabilities and Shareholders Equity over the past 4 years, most recently at $39.3 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 4.91% to $39.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $150.0 million through Mar 2026, down 23.86% year-over-year, with the annual reading at $43.3 million for FY2025, 10.72% down from the prior year.
- Liabilities and Shareholders Equity was $39.3 million for Q1 2026 at Adagio Medical Holdings, down from $43.3 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $107.2 million in Q3 2024 and troughed at $6.8 million in Q4 2023.
- The 4-year median for Liabilities and Shareholders Equity is $40.3 million (2025), against an average of $44.2 million.
- Year-over-year, Liabilities and Shareholders Equity surged 609.86% in 2024 and then plummeted 70.57% in 2025.
- A 4-year view of Liabilities and Shareholders Equity shows it stood at $6.8 million in 2023, then surged by 609.86% to $48.4 million in 2024, then fell by 10.72% to $43.3 million in 2025, then dropped by 9.12% to $39.3 million in 2026.
- Per Business Quant, the three most recent readings for ADGM's Liabilities and Shareholders Equity are $39.3 million (Q1 2026), $43.3 million (Q4 2025), and $31.5 million (Q3 2025).